We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more visit Cookies: How we use the information on our website. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Our latest news and events
New research part-funded by NIHR Maudsley BRC, and led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London in collaboration with the NIHR ARC North Thames at University College London and NHS Trusts across England, has found that healthcare workers experience post-traumatic stress disorder (PTSD) at twice the rate of the general public.
By NIHR Maudsley BRC at 12 Dec 2022Researchers from King’s College London have shown that when brain cells are directly exposed to blood taken from COVID-19 patients with delirium, there is an increase in cell death and a decrease in the generation of new brain cells. Delirium represents a state of confusion indicating that, in these patients, the COVID-19 infection had impacted the brain.
By NIHR Maudsley BRC at 5 Oct 2022A new study has analysed over 3000 proteins to identify which are causally linked to the development of severe COVID-19. This is the first study to assess such a large number of proteins for their connection to COVID-19. The findings provide insight into potential new targets for approaches to treat and prevent severe COVID-19.
By NIHR Maudsley BRC at 3 Mar 2022
Dr Basak Tas, Dr Amir Englund and Dr Stephen Sharman are all researchers in the Centre for Addiction Research, King’s College London. Recently they published an article in the journal Addiction where they discussed the challenges and advantages that the pandemic has brought through the shift to more remote research. In this blog they summarise their conclusions.
By NIHR Maudsley BRC at 21 Feb 2022UK drugs regulator, the Medicine and Healthcare products Regulatory Agency (MHRA) has approved Novavax's Nuvaxovid vaccine, which was trialled at the King's CRF, for use in the UK.
By NIHR Wellcome King's Clinical Research Facility at 16 Feb 2022
The NIHR Maudsley Biomedical Research Centre (BRC) is part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. We are part of King’s Health Partners Academic Health Sciences Centre.
© NIHR Maudsley Biomedical Research Centre 2025 | Website design by CSMB Design | All rights reserved.
